July 10 2012 -- Edmond de Rothschild Investment Partners is pleased to announce the first closing and
launch of the fourth fund in its BioDiscovery franchise dedicated to investing in Life Sciences
in France and in Europe.
Thanks to the renewed confidence of its existing institutional investor base as well as new investors
who decided to participate in this new fund Edmond de Rothschild Investment Partners reached its
objective of €125 million for the first closing in the expected timeframe and confirms its final objective
of about €200 million by the end of the year.
Edmond de Rothschild Investment Partners will deploy the same strategy for BioDiscovery 4 as for its
previous funds. The team will lead investments in 15 to 20 life science companies across all stages of
development. The investments will be made both in therapeutic drug development companies and a
combination of medical technology and molecular diagnostic companies. The fund will invest mainly in
About Edmond de Rothschild Investment Partners
Paris-based Edmond de Rothschild Investment Partners is dedicated to minority investments into
privately-owned companies. It has currently €1 billion under management which is being invested
primarily in Life Sciences Venture Capital and Growth Capital.
Its Life Sciences team of eight professionals brings together over 50 years of experience in the Life
Science industry and more than 100 years of private equity and venture capital experience. The team
now has €355 million under management through its BioDiscovery funds.
Edmond de Rothschild Investment Partners is an independently managed affiliate of Edmond de
Rothschild Group. For more information please visit: www.edrip.fr.
About Edmond de Rothschild Group
Edmond de Rothschild Group is an independent, family-owned group focused on private banking and
asset management. Founded in 1953, Edmond de Rothschild Group has been chaired since 1997 by
the founder's son, Baron Benjamin de Rothschild. The Group has more than $150 billion in assets
under management and 2,700 employees in 30 offices around the world. In addition to its main
activities in asset management and private banking, the Group’s financial activities include fund
administration and corporate advisory services.
This document is for information only. Any investment in private equity through capital development or
venture capital funds involves specific risks like capital loss risk, discretionary management risk and
liquidity risk. All potential investors should liaise with their service provider or advisor to make their
own opinion on the inherent risks to each investment independently of Edmond de Rothschild
Investment Partners and on such investment suitability with their needs and personal circumstances.
EDMOND DE ROTHSCHILD INVESTMENT PARTNERS 47, rue du Faubourg Saint-Honoré -75401
Paris Cedex 08 A simplified joint-stock company registered under French law with a capital of EUR
501,500 - 444 071 989 R.C.S. Paris.